Adam Hardy

Adam Hardy PhD is a seasoned professional in commercial operations and business development within the pharmaceutical and clinical research sectors. Currently serving as the Senior Vice President of Commercial Operations at EVERSANA since May 2019, Adam has played a pivotal role in stabilizing the business post-merger, leading to a 300% headcount increase and enhanced M&A activities. Previous experiences include positions as Vice President and Senior Director at Medpace, where Adam established a European proposals capability and managed global proposals. Adam's career also encompasses leadership roles at inVentiv Health Clinical and Physiomics Plc, along with research positions at the University of Bristol and Thomas Jefferson University. Adam holds a Ph.D. in Pharmacology from the University of Bristol and has a BSc in Pharmacology with Study in Industry.